The effects of camptothecin on RNA polymerase II transcription: Roles of DNA topoisomerase I
- 21 January 2007
- Vol. 89 (4) , 482-489
- https://doi.org/10.1016/j.biochi.2007.01.001
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- ATM and ATR Pathways Signal Alternative Splicing of Drosophila TAF1 Pre-mRNA in Response to DNA DamageMolecular and Cellular Biology, 2006
- Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNAThe EMBO Journal, 2006
- Early Effects of Topoisomerase I Inhibition on RNA Polymerase II Along Transcribed Genes in Human CellsJournal of Molecular Biology, 2006
- Cancer therapeutics: Targeting the dark side of MycEuropean Journal Of Cancer, 2005
- SF2/ASF protein binds to the cap region of human topoisomerase I through two RRM domainsBiochemical and Biophysical Research Communications, 2005
- DNA Topoisomerase I Is a Cofactor for c-Jun in the Regulation of Epidermal Growth Factor Receptor Expression and Cancer Cell ProliferationMolecular and Cellular Biology, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- The Transcriptional Inhibitors, Actinomycin D and α-Amanitin, Activate the HIV-1 Promoter and Favor Phosphorylation of the RNA Polymerase II C-terminal DomainJournal of Biological Chemistry, 1999
- Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.Genes & Development, 1997
- Transcription by RNA polymerase II induces changes of DNA topology in yeast.Genes & Development, 1988